Category: Uncategorized
-
Delhi High Court orders Korean defendant to deposit $43 million in patent infringement dispute
A $35 million security deposit comes on top of a $8 million deposit already ordered in the same dispute in 2019.
-
UPC Roundup (2 weeks): separate fees for appeals of revocation claims and of revocation counterclaims even if jointly decided; other clarifications, new cases
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our June 21, 2025 UPC Roundup. The first week after the previous roundup was slow because of a UPC-internal event we mention further below, which is why we exceptionally extended the roundup period. 1. CoA 1.1 CoA rejects…
-
Ericssonâs assertion and enforcement head Robert Earle on the merits of arbitration
In this interview, Mr. Earle discusses the merits of arbitration, the growing role of the Unified Patent Court in patent enforcement strategies, and his stance on UK courts issuing interim license declarations.
-
Nokiaâs chief litigation counsel and FSA director clash over Big Tech involvement in proposed EU SEP Regulation lobbying activities
The Fair Standards Allianceâs director Robert Pocknell has claimed Apple was not involved in the founding of his organization, which was set up in the interest of SMEs â and that SEP regulation discussions started at the European Commission way before it was founded.
-
âBrain drainâ in German district courts makes UPC the new âstandardâ in global patent enforcement campaigns, says local patent attorney
Jako Eleveld of Philips and Bernhard Thum of Thum & Partner have agreed with Bardehle Pagenbergâs Tobias Wuttke that the UPC has become the âdefault settingâ for EU patent litigation, which he noted at the 2nd Annual IP Dealmakers Europe in London yesterday.
-
UPC Roundup (1 week): new Swedish Patent Office evidence in TCL case; phased rollout of new Case Management System; various new cases
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our June 8, 2025 UPC Roundup. 1. CoA: intervener’s bid to halt enforcement of infringement ruling denied (Chainzone Technology (intervener) v. SWARCO) (link to LinkedIn post) The Court of Appeal (CoA) second panel rejected Chainzone’s application to suspend…
-
Two U.S. pharma patent disputes fail to make it to trial: Alnylam concedes first round of litigation against Pfizer, BioNTech in COVID vaccine war, Nexus obtains summary judgment of invalidity
While Alnylam has dropped its patent infringement dispute against Pfizer, BioNTech, and Ingenus Pharmaceuticals has failed to take its cancer dispute to trial, both cases are subject to appeal.
-
10x Genomics and Bruker (NanoString) end global patent dispute
The UPCâs first major patent dispute has ended after the companies signed a global cross-license patent agreement.
-
Erich Spangenbergâs SIM IP inks Europe-focused patent monetization deal, leverages 1,000 AI-focused patents
This is the young companyâs second major patent transaction in less than a week, as it gears up to have its stock publicly traded.
-
Federal Circuit hands win to Fox in machine learning patent infringement dispute
âClaims that do no more than apply established methods of machine learning to a new data environmentâ are not patent eligible, the United States Court of Appeals for the Federal Circuit has ruled in dismissing an appeal filed by plaintiff Recentive Analytics.